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Background 
HBV infection is a major global public health problem. 
It is estimated that between 350 to 400 million people 
are hepatitis B virus (HBV) carriers in the world, approxi-
mately 1 million of whom die from HBV-related liver 
ABSTRACT
Background: Hepatitis B virus (HBV) infection is a significant health problem through-
out the world.
Objectives: We aimed to evaluate the prevalence of hepatitis B antigen (HBsAg) serop-
ositivity in the general population of Mashhad, northeast of Iran.
Patients and Methods: One thousand six hundred fifty-two healthy individuals aged 1 
to 90 (Mean; 29.1 ± 18.5) from all 12 municipalities of Mashad were selected randomly 
by multistage cluster sampling. Informed consent was obtained, and demographics 
and medical histories were collected. Twice-reactive samples were considered HBsAg-
positive by ELISA. Chi-square test and logistic regression were applied to analyze the 
factors related to HBsAg positivity using SPSS 16.0. 
Results: The overall prevalence of HBsAg positivity was 1.39% (95% CI, 0.91% to 2.12%); 
2.0% and 0.89% among men and women, respectively (p = 0.054). Infection was more 
prevalent in older (p = 0.019) and married persons (p = 0.001), Afghanis (p = 0.046), 
and those with a history of traditional cupping (p = 0.005). There was no association 
between HBV infection and gender; literacy; income; employment; family size; or his-
tory of blood transfusion, dental procedure, surgery, hospitalization, or tattooing. By 
logistic regression analysis, age was the only variable that had a significant association 
with infection (p = 0.026).
Conclusion: It seems that the prevalence of HBV infection in Mashhad is slightly lower 
than that of the nation. 
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diseases annually (1, 2). The prevalence of HBV infection 
differs throughout the world. There are low-prevalence 
areas, such as the United States, Canada, western Europe, 
Australia, and New Zealand, in which the prevalence is 
0.1% to 2%; intermediate-prevalence areas, such as Medi-
terranean countries, Japan, central Asia, the Middle East, 
and Latin and South America (2% to 8%); and high-preva-
lence areas, such as southern Asia, China, and sub-Saha-
ran Africa (8% to 20%) (3, 4).
The Islamic Republic of Iran (Iran) is an intermediate 
endemicity area regarding the prevalence of HBV in the 
general population (5). Initial studies have estimated 
that more than 50% of Iranian patients with cirrhosis 
and about half of those with hepatocellular carcinoma 
are HBV carriers (6). Further, up to 3.9% of Iranians are 
HBsAg-positive (7). Similarly, Farzadegan et al. (1979) re-
ported an incidence of HBsAg of 3.4% and 8.4% among vol-
untary and professional blood donors, respectively (8).
Conversely, recent studies have demonstrated that the 
prevalence of HBV infection among the general popula-
tion and blood donors in Iran has declined (5, 9). A sys-
tematic review in 2008 estimated the prevalence of HBV 
infection in Iran to be 2.14% - 2.55% and 2.03% among males 
and females, respectively (9). It has been suggested that 
the observed decline is due to the inclusion of neonates 
in the national HBV vaccination program since 1993 and 
the vaccination of high-risk groups against HBV (10-12). 
Also, a nationwide study by the Iranian Blood Transfusion 
Organization (IBTO) stated that the incidence of HBsAg 
among voluntary blood donors declined significantly 
from 1.8% in 1998 to 0.4% in 2007 (5), which could be ex-
plained by the blood safety measures that were imple-
mented by the IBTO across the country, such as improved 
donor selection and exclusion of replacement donations 
(5). The modes of transmission for HBV include perinatal 
infection, unprotected sexual contact, intravenous drug 
use, and blood transfusion. The chief route of transmis-
sion differs between regions. In high-prevalence areas, 
perinatal infection is the major route (13). However, in 
intermediate-prevalence areas, horizontal transmission, 
especially in early childhood, causes most chronic HBV 
infections, and unprotected sexual intercourse and in-
travenous drug use in adults are the principal transmis-
sion routes in low-prevalence areas (14). 
Mashhad, the center of Khorasan-e-Razavi province, 
in the northeast of Iran, is its second largest city, with 
a population of 2.4 million. It attracts about 20 million 
pilgrims annually as an important holy city. There have 
been few studies regarding the prevalence of HBV infec-
tion in the general population of this area. A cross-sec-
tional study on healthy population in the range of 2-100 
years of Khorasan province in 1998 calculated an HBsAg-
positive rate of 3.6% (15). Ghanaat, et al. tested 1500 indi-
viduals who underwent an STD examination in Mashhad 
between 1998 and 2000, determining a seroprevalence of 
HBsAg in 12.2% and 14.3% of 90 persons with gonorrhea 
and 70 with syphilis, respectively (16). Also, per Khorasan-
e-Razavi Blood Transfusion Organization reports, 1.2% of 
donors who were admitted to blood transfusion centers 
during 2001 to 2005 were HBsAg-positive (17). 
Objectives
The present study was conducted to determine the 
prevalence of hepatitis B antigen and its related factors 
in the general population of Mashhad, Iran.
Patients and Methods
In this cross-sectional study, 1678 apparently healthy 
residents of Mashhad were selected by multistage clus-
ter sampling from all 12 municipalities between May and 
September 2009. Pilgrims and high-risk groups, such as 
hemodialysis patients, were not included in this survey. 
These 12 areas included 40 districts, and each district 
Variable No. Positive (%) P-value
Sex
Male
Female
749
903
2.00
0.89
0.054
Age (years) a
< 6
6-11
12-16
17-20
21-24
25-29
30-34
35-44
45-54
≥ 55
129
155
157
183
180
179
132
190
161
186
0.78
0.00
0.00
0.55
0.00
2.23
0.76
3.16
2.48
3.23
0.019
Marital status (people older than 14)
Single
Married
Divorced/widowed
416
774
57
0.48
1.94
7.02
0.001
Ethnic background
Iranian
Afghani
1576
61
1.21
4.92
0.046
Literacy (people older than 6)
Illiterate
Primary-secondary school 
(1-8 years)
High school (9-12 years)
Academic
110
628
495
265
1.82
1.59
1.82
0.38
0.43
Household monthly income 
(million Rials) b
< 3
3-5
> 5
799
544
224
1.63
1.65
0.45
0.39
Employment (people older than 14)
Unemployed
Employed
677
489
2.44
1.03
0.059
Family Size
1-2
3-4
≥ 5
213
707
635
2.82
1.13
1.42
0.20
Table 1. Sociodemographic factors related to HBsAg positivity in the general 
population of Mashhad, Iran
a Ten percentiles for age according to the 2006 census 
b 1 million Rials is equal to about 100 USD.Hepat Mon. 2011;11(5):346-350
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had many subdivisions. First, we estimated the number 
of households that was proportional to the total popula-
tion in every district. Next, one subdivision was selected 
randomly from every district, and some blocks were cho-
sen randomly in every subdivision. Next, the total num-
ber of households in each selected block was estimated, 
and at least 20 households were chosen in each block by 
systematic random sampling method. Finally, 1 person 
was selected in each household, and we tried to include 
equal numbers of the both genders; we also established 
percentiles by age according to the 2006 census (less 
than 6 years, 6-11, 12-16, 17-20, 21-24, 25-29, 30-34, 35-44, 
45-54, and 55 and older). The study was approved by the 
Research Deputyship of the Iranian Academic Center for 
Education, Culture & Research (ACECR) regarding meth-
odological and ethical issues. The study purpose was 
clearly discussed with the participants, and informed 
consent was obtained (for children, the informed con-
sent was obtained from their parents), and demographic 
characteristics and medical histories, including history 
of blood transfusion, dental procedures, surgery, hospi-
talization, and traditional cupping, were collected using 
a questionnaire.
Five-milliliter venous blood samples were obtained 
from each individual. Serum was separated by centrifu-
gation, and samples were stored at -20°C. Serum samples 
were screened for HBsAg by ELISA using the EIAgen HB-
sAg Kit (Adaltis Italia S.p.A., Italy) per the manufacturer’s 
instructions. Twice-reactive samples by ELISA were con-
sidered HBsAg-positive. Data were expressed as mean, 
standard deviation, and percentages and were analyzed 
by chi-square test using SPSS 16.0. Logistic regression was 
used to analyze the factors related to HBsAg positivity. A p  
< 0.05 was considered statistically significant. 
Results
One thousand six hundred seventy-eight individuals, 
ranging from 1 to 90 years, were enrolled; 763 (45.5%) 
were male and 915 (54.5%) were female, and the mean age 
was 27.9 ± 19.0 and 30.0 ± 18.1 years, respectively. Twenty-
six persons refused to have blood taken and were exclud-
ed from subsequent analyses. In the screen of 1652 serum 
samples by ELISA, 23 (1.39%) (15 men and 8 women) were 
positive for HBsAg (95% CI, 0.91% to 2.12%). No significant 
relation were observed between genders and positivity 
of HBsAg (p = 0.054) (Table 1).
HBV infection was significantly associated with age. 
HBsAg-positive individuals were considerably older 
than others (42.7 ± 18.2 vs. 28.9 ± 18.4 years, respectively, 
p < 0.001). The prevalence of HBV infection was 0.26% in 
people under 15, 0.24% in 15–24-year olds, 1.61% in 25–34-
year olds, and 2.98% in those above 35 years (p = 0.003). 
In individuals under 25 years, HBsAg was detected in 2 
persons—a 4-year-old Afghani child born in Isfahan, Iran, 
with a history of 3 HBV vaccinations, and an 18-year-old 
single man who was born in Mashhad, without a history 
of HBV immunization. 
By univariate analysis, HBV infection was also associated 
with being married (p = 0.001), being Afghani (p = 0.046), 
and having history of traditional cupping (Hijamat) (p = 
0.005) (Tables 1 and 2). There was no association between 
HBV infection and literacy, family size, monthly income, 
employment, or a history of blood transfusion, surgery, 
hospitalization, dental procedure, and tattooing. Bina-
ry logistic regression analysis was used to estimate the 
potential risk factors of infection. The variables in the 
equation showed in Table 3 were age (< 25 vs. 25 years and 
above), marital status (single vs. married at least once), 
ethnicity (Iranian vs. Afghani), and a history of tradi-
tional cupping (no vs. yes). Being older than 25 years was 
the only factor that predicted the risk of infection (p = 
0.026).
Discussion
HBV infection is considered a major public health 
problem in the world, involving many people in many 
countries (1, 2). Iran is located in the Middle East, which 
is known as an area with an intermediate to high preva-
lence of HBV infection; however, there are differences 
between countries in this region (4). Bahrain and Kuwait 
Variable No. Positive (%) p-value
Transfusion
Yes
No
63
1543
3.17
1.36
0.24
Hospitalization
Yes
No
626
1013
1.28
1.48
0.74
Surgery
Yes
No
551
1089
1.63
1.29
0.57
Dentistry procedure
Yes
No
348
1278
2.59
1.10
0.37
Tattooing
Yes
No
53
1573
3.77
1.34
0.17
Traditional cupping
Yes
No
233
1398
3.43
1.07
0.005
Table 2. Medical factors related to HBsAg positivity in the general population 
of Mashhad, Iran
Variable p-value OR a 95% CI b
Age  0.026 9.80 1.31-73.46
Marital Status 0.527 1.68 0.34-8.43
Ethnic background 0.098 3.60 0.79-16.38
Traditional cupping 0.476 1.43 0.54-3.80
Table 3. Logistic regression analysis of the association of HBsAg positivity 
with selected variables (Mashhad, Iran, 2009)
a OR: Odds Ratio
b CI: Confidence IntervalHepat Mon. 2011;11(5):346-350
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are areas with low endemicity, with HBsAg carrier rates 
under 2%. These countries have included hepatitis vac-
cination as a part of their Expanded Program on Immu-
nization, covering over 80% of the population. Countries 
with intermediate endemicities in this region include 
Cyprus, Iraq, and the United Arab Emirates, with carrier 
rates of 2% to 5% in their general population. Areas of 
high endemicity include Egypt, Jordan, Oman, Palestine, 
Yemen, and Saudi Arabia, with carrier rates of 2% to 18.5% 
in their general population (18). 
Studies have indicated that the prevalence of HBV in-
fection differs among the general population between 
various parts of Iran. In the present study, we found that 
the overall HBsAg positivity in the general population 
of Mashhad, located in Khorasan-e-Razavi province, was 
1.39%, which is lower than the national prevalence (2.14%) 
(9); however ,the confidence intervals in mentioned 
studies overlap. Abdolahi, et al. reported the highest 
prevalence of HBsAg among the general population of 
Golestan province, 8.86%, which was equivalent to high-
endemicity areas (19). Also, the prevalence of HBsAg in 
the general population of Golestan (city of Gonbad), Hor-
mozgan, and Hamedan (city of Nahavand) provinces is 
4.3%, 2.4%, and 2.3%, respectively, which are equivalent to 
rates in intermediate endemicity areas (9, 20, 21).
Conversely, Nokhodian, et al. (22) and Bayat-Makou, et 
al. (23) reported 1.3% and 1.2% prevalence rates for HBsAg 
in the general population of Isfahan and Azarbayejan 
(city of Tabriz) provinces, respectively, which are equal to 
those in low endemicity areas. We noted higher rates of 
HBsAg positivity in the general population than in blood 
donors in Mashhad (17). This finding is expected because 
the high-risk group was screened prior to blood dona-
tion. 
We have also noted that the prevalence of HBV has de-
creased dramatically in the last decade in Iran, which 
now renders it an area with low endemicity (12). Several 
factors could contribute to the decrease in HBV infec-
tion in Iran and in this study. The most important factor 
could be the implementation of a national vaccination 
program in 1993 for all neonates as a part of an Expanded 
Program on Immunization (EPI). The coverage rate of 
this vaccination program has reached 99%, according to 
national data from 2009 (24). Also the immunization of 
high-risk groups, such as health care workers and blood 
product recipients, as recommended by national vacci-
nation program, could be another important factor in 
the reduction of HBsAg positivity (12, 25). Consistent with 
many studies in Iran (11, 22, 26), our study showed that 
the prevalence of HBV infection is significantly higher 
among older people. The very low prevalence of HBsAg 
among people aged younger than 17 years demonstrates 
that the national vaccination program for neonates is an 
effective method of reducing infections. Moreover, the 
3-round HBV vaccination campaigns were implemented 
for 17-year-olds in 2007 (27), meaning that individuals 
aged older than 17 years at the time of this study had no 
received active immunization against HBV through the 
national vaccination programs for neonates and adoles-
cents. Nevertheless, such programs might also play an im-
portant role in the very low prevalence of HBV infection 
among those aged older than 17 years, probably due to the 
reduction in intrafamilial transmission. The results of 2 
large-scale national seroepidemiological surveys in Iran 
showed a significant decline in the seropositivity rate in 
the 2–14 but not 15–69-year-olds between 1991-1999 (11). 
HBV carrier rates fell from 1.3% in 1991, 2 years before the 
launch of the national HBV vaccination program, to 0.8%, 
6 years after the launch in 1999 in this age group. Increas-
es in people’s knowledge about HBV risk factors through 
the media and educational programs for students could 
also affect the prevalence of infection, especially among 
youth. On the other hand, the increased possibility of 
intrafamilial transmission in older individuals could 
explain the age-related trend of infection. We found that 
HBV infection was more prevalent in men than women, 
although this difference was not significant. This finding 
has been confirmed in previous studies (11, 26), whereas 
others do not support it (20, 22).
Our study also noted a higher prevalence of HBsAg 
among married people versus singles. In Iran, the aver-
age age at first marriage is 26.2 and 23.2 years for men 
and women, respectively (28). Thus, most married people 
have not been included in the national vaccination pro-
grams and are not protected against the infection. Yet, 
sexual contact is one of the common transmission routes 
for HBV infection, and the probability of acquiring the 
infection from an HBsAg-positive person’s sexual partner 
is 4% to 15% (29). Compared with western countries, pre-
marital sexual relationships in the Iranian community 
are expected to be rare due to special cultural and reli-
gious backgrounds (29), meaning that sexual transmis-
sion of HBV infection between spouses might be a reason 
for the higher prevalence of infection among married 
people. Finally, our study observed a higher prevalence of 
HBsAg among people of Afghani ethnicity. Quddus, et al. 
reported an 8.3% rate of HBsAg positivity among Afghan 
refugees in a camp in Balochistan, Pakistan (30). Thus, it 
would be valuable to monitor HBV infections among for-
eign immigrants in cities with large immigrant popula-
tions, such as Mashhad.
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